Kingstone (KINS) Form 4: Randy Patten Granted 43,290 Shares with 3-Year Vesting
Rhea-AI Filing Summary
Kingstone Companies, Inc. (KINS) Form 4: Randy L. Patten, serving as CFO, VP and Treasurer and a director, reported an acquisition of 43,290 shares of common stock on 08/25/2025 as a restricted stock grant. The reported price is shown as $0, reflecting that the shares were issued pursuant to a grant rather than a cash purchase.
The filing specifies a vesting schedule: 10,823 shares vest on 08/25/2026, 10,822 shares on 08/25/2027 and 21,645 shares on 08/25/2028. The reporting form is filed by one reporting person and is signed by Randy L. Patten.
Positive
- Insider alignment: CFO granted 43,290 restricted shares, which ties executive compensation to long-term shareholder value
- Clear vesting schedule: Vesting tranches disclosed for 2026, 2027 and 2028, supporting retention incentives
Negative
- None.
Insights
TL;DR: Insider received a restricted stock grant of 43,290 shares with multi-year vesting, indicating compensation alignment rather than an outright market purchase.
The grant of 43,290 restricted shares to the CFO is a compensation event that aligns management incentives with shareholders over a three-year vesting period. The report records the issuance at $0, consistent with equity compensation accounting where no cash changed hands. This disclosure does not provide company-wide dilution metrics or percentage ownership post-grant, so the material impact on share count and EPS cannot be assessed from this Form 4 alone. For valuation impact, combine this with outstanding share data from the company's periodic filings.
TL;DR: Restricted stock grant with staged vesting reflects standard governance practice to retain and incent senior management.
The staged vesting schedule (2026, 2027, 2028) is a typical governance mechanism to promote retention and align executive performance with long-term objectives. The Form 4 properly discloses the grant, vesting tranches, and the reporting officer's roles. The filing does not indicate any accelerations, liens, or derivative instruments tied to these shares. Without additional context on total outstanding shares or prior grants, the governance significance is limited to confirming routine executive compensation disclosure.